Updated Jul 16, 2026
MCDONNELL MICHAEL R has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $330K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | MMSI | MERIT MEDICAL SYSTEMS INC | A — Grant or award | 3.5K | $0.00 | |
| 2026-05-07 | BAX | BAXTER INTERNATIONAL INC | A — Grant or award | 12.8K | $0.00 | |
| 2026-02-18 | BAX | BAXTER INTERNATIONAL INC | A — Grant or award | 1.8K | $0.00 | |
| 2025-05-30 | MMSI | MERIT MEDICAL SYSTEMS INC | S — Open-market sale | 1.8K | $94.51 | $165K |
| 2025-05-30 | MMSI | MERIT MEDICAL SYSTEMS INC | S — Open-market sale | 1.8K | $94.30 | $165K |
| 2025-05-15 | MMSI | MERIT MEDICAL SYSTEMS INC | A — Grant or award | 2.2K | $0.00 |
MCDONNELL MICHAEL R is a corporate insider — currently tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($330K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MCDONNELL MICHAEL R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.